HER2-Targeted Strategies for HER2-Positive Gastro and Colorectal Cancers — John Strickler, MD

Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Ca...Подробнее

Advances in targeted therapies for colorectal cancerПодробнее

Targeting HER2 in colorectal cancerПодробнее

S1 Episode 4: Breakthroughs in HER2-Amplified Colorectal CancerПодробнее

Overview of recent changes to the treatment landscape for HER2-positive CRCПодробнее

Real-world treatment patterns for HER2-amplified colorectal cancerПодробнее

Dr. John Strickler on HER2-Positive Colorectal Cancer Treatment Advances | ASCO 2024Подробнее

Integrating HER2-Targeted Strategies into the Management of Gastrointestinal CancersПодробнее

HER2-Positive Gastrointestinal Cancers: New Evidence and Practical Guidance With Targeted AgentsПодробнее

Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastro CancersПодробнее

HER2 Targeted TherapiesПодробнее

Targeting HER2 in Colorectal CancerПодробнее

Drs. Schalper, Press, Tarantino & Wainberg discuss #HER2, #HER3, & #TROP2: https://bit.ly/37BH4EkПодробнее

Targeted therapies for patients with HER2+ colorectal cancerПодробнее

Targeted Therapy for HER2-positive Breast Cancer AnimationПодробнее

HER2-Positive Metastatic Colorectal Cancer: Unraveling Game-Changing Treatment ApproachesПодробнее

HER2 Testing in MetastaticColorectal Cancer (mCRC)Подробнее

Updated analysis from MOUNTAINEER: tucatinib and trastuzumab for HER2-positive mCRCПодробнее

Strategies to overcome resistance to targeted therapies in colorectal cancerПодробнее